Key points are not available for this paper at this time.
To determine the effective and safe intravenous doses of mesenchymal stem cells (MSCs)-derived microvesicles (MVs) and to elucidate the possible causes of death in mice receiving high-dose MVs.
Wei et al. (Mon,) studied this question.